Skip to main content
Mobile TB clinic

Eswatini

Eswatini (formerly Swaziland) has one of the world’s highest rates of HIV, with nearly one in three adults living with the disease. However, around 80 per cent of people with TB in Eswatini are HIV positive.

Estimates suggest that HIV incidence rates in Eswatini have fallen in recent years, as significant progress has been made in improving the number of people receiving antiretroviral (ARV) treatment.

We continue to help more HIV patients access ARV treatment through the ’test and start’ strategy. A team has been piloting ‘test and start’ in the Nhlangano project; after HIV testing, ARV treatment was offered to more than 1,700 people after a positive HIV diagnosis to immediately start treatment.

We now treat patients with extensively drug-resistant TB (XDR-TB), and those developing severe side effects, using the promising new drugs bedaquiline and delamanid in combination with repurposed drugs.

Our activities in 2023 in Eswatini

Data and information from the International Activity Report 2023

MSF in Eswatini in 2023 In 2023, Médecins Sans Frontières (MSF) opened a new project in Eswatini, aimed at tackling sexual health-related illnesses through innovative practices and community engagement.
Eswatini IAR Map 2023

MSF had been providing health services in Shiselweni region since 2007, focusing on HIV, drug-resistant tuberculosis (DR-TB) and, during the pandemic, COVID-19. After successfully decentralising HIV and DR-TB care by bringing treatment closer to people’s homes, and lowering HIV incidence, all these activities were handed over to Ministry of Health and local partners, and the project closed in 2023.

Sexual health-related diseases, such as HIV, sexually transmitted infections (STIs) and cervical cancer, as well as the complications of unsafe abortions, remain significant health issues in Eswatini. An STI study conducted by MSF in Shiselweni showed that one-third of the patients attending outpatient consultations in six general healthcare facilities have at least one STI.

Based on this research and a detailed assessment, we opened a new sexual health project in Manzini region in the last quarter of 2023. The project provides comprehensive sexual health services, including STI testing and treatment; HIV testing and prevention; screening, prevention and treatment for hepatitis B and C and cervical cancer; and family planning at a dedicated MSF clinic in Matsapha Industrial Area and in the communities.

The project brings multiple practices to the country, such as laboratory-based diagnosis and treatment of STIs; molecular screening for cervical cancer; injectable pre-exposure prophylaxis for HIV; screening and treatment of hepatitis B and C, as well as hepatitis B vaccination; and online HIV counselling and self-testing.

The project implements MSF’s ‘Patients and Populations as Partners’ approach, through close engagement with communities.
 

In 2023
 
Fighting HIV and TB dual epidemic
Eswatini

MSF hands over HIV and TB programme in Eswatini after 16 years

Voices from the Field 26 May 2023
 
HIV MEDICATIONS
HIV/AIDS

Pharmaceutical company ViiV must provide transparency on HIV prevention drug

Press Release 30 Mar 2023
 
Mozambique - Jose Macamo Project - HIV
Coronavirus COVID-19 pandemic

Ravaged by new strain, southern Africa must get COVID-19 vaccines

Press Release 3 Feb 2021
 
Video Observed Therapy (VOT) training for MDR-TB patients in Matsanjeni health centre
Coronavirus COVID-19 pandemic

Eswatini: Responding to COVID-19 in a country already fighting a dual HIV/TB epidemic

Interview 8 May 2020
 
Malawi - Advanced HIV
HIV/AIDS

AIDS death toll stagnating due to lack of testing at community level

Press Release 1 Dec 2019
 
Malawi - Advanced HIV
HIV/AIDS

MSF report "No time to lose" examines the fight against AIDS in 15 countries

Report 27 Nov 2019

find us online